NDC 51662-1249-2 - PHENYLEPHRINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1249
- Requested NDC
- 51662-1249-2
- Package NDCs from labels
- 51662-1249-1, 51662-1249-2, 51662-1249-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-02-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHENYLEPHRINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1249-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-0c46-f424-e053-dadaa90a57ce | PHENYLEPHRINE HCI INJECTION, USP 10mg/mL 1mL VIAL |
| 51662-1249-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0c46-f424-e053-dadaa90a57ce | PHENYLEPHRINE HCI INJECTION, USP 10mg/mL 1mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1249-1 | PHENYLEPHRINE HCI | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 8 | |
| 51662-1249-2 | PHENYLEPHRINE HCI | 1 mL in 1 POUCH | INJECTION | 1 | 8 | |
| 51662-1249-3 | PHENYLEPHRINE HCI | 25 in 1 CASE | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1249 | PHENYLEPHRINE HCI INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 8 | Current NDC, Legacy NDC, 3 package rows | 20240224_7602fb73-3ce3-5978-e053-2991aa0abea3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AGRIFEN | ACETAMINOPHEN, DEXTOMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC | 31aaa8e7-7980-1e00-e063-6294a90a18d0 | 2026-09-29 | Warnings | 04JA59TNSJ |
| SINUS PAIN AND CONGESTION DAYTIME | ACETAMINOPHEN AND PHENYLEPHRINE HCL | CVS Pharmacy | c878c7aa-c591-4bae-a1d1-842eaf27c5b1 | 2026-09-29 | Warnings | 04JA59TNSJ |
| Cold, Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreen Company | 3666cf90-54f8-4bd0-a1de-f77c97f1c045 | 2026-09-29 | Warnings | 04JA59TNSJ |
| Cold and Flu plus Congestion Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | WALMART INC. | 1236b463-0073-44b5-a516-5b7c06a40887 | 2026-09-28 | Warnings | 04JA59TNSJ |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| DAYTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Amazon.com Services LLC | 692a9fa1-b251-489e-8978-3ed92e192d08 | 2026-09-24 | Warnings | 04JA59TNSJ |
| TYLENOL Cold Plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | efb3bfc5-72e9-4221-8d03-e48f3d8e3821 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | ba59657e-a16e-46b2-998d-45dd71095d7a | 2026-09-24 | Warnings | 04JA59TNSJ |
| Sinus Pressure plus Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | e9a3cb81-2d45-4fc2-80f9-7fde71b3e81d | 2026-09-24 | Warnings | 04JA59TNSJ |
| Cold Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | 590c699a-9d87-43db-aef4-2615af07a6b6 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | e33b8911-5f5c-c037-e053-2a95a90adb2e | 2026-09-24 | Warnings | 04JA59TNSJ |
| Mucus Relief Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | b2090b31-dc0a-2cd4-e053-2a95a90a414e | 2026-09-24 | Warnings | 04JA59TNSJ |
| Mucus Relief Sinus Pressure Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | e547024f-fbf0-fc9a-e053-2995a90afe19 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl | ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | OPMX LLC | 9a164cfc-b623-9a9f-e053-2a95a90a0173 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Tesalon Jarabe Adulto | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN USP, PHENYLEPHRINE HCL | OPMX LLC | 231c6455-4198-feec-e063-6394a90a8541 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Pentrexcilina Children TOTAL RELIEF Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN USP, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC | 2bc10608-ddba-1e68-e063-6294a90aef67 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Pentrexcilina Adult TOTAL RELIEF Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN USP, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC | 2bef3b6f-456a-5b76-e063-6394a90aa116 | 2026-09-24 | Warnings | 04JA59TNSJ |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| Rugby Eye Wash | WATER, PURIFIED | Rugby Laboratories | 1fee974b-4c29-4965-bd3d-da5e219eb13a | 2026-09-24 | Warnings | 059QF0KO0R |
| Emetrol Chewables | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9880a18a-cf84-47cd-99b5-d692065a25bf | 2026-09-24 | Warnings | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.